Electroconvulsive Therapy for Treatment-Resistant Schizophrenia

Diarmid J. M. Sinclair; Sai Zhao; Fang Qi; Kazare Nyakyoma; Joey S. W. Kwong; Clive E. Adams

Disclosures

Schizophr Bull. 2019;45(4):730-732. 

In This Article

Objectives

Our primary objective was to assess the effects (benefits and harms) of ECT for people with treatment-resistant schizophrenia. Our secondary objectives were to determine whether ECT produces a differential response in those treated with unilateral compared with bilateral ECT, long (more than 12 sessions) compared with a short course ECT, continuation compared with maintenance ECT, well-defined treatment-resistant schizophrenia compared to less well-defined treatment-resistant schizophrenia (who would be expected to have a greater affective component to their illness).

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....